Cargando…

Overview of Blood Transfusion System of Iran: 2002–2011

Despite importance of blood transfusion services as life saving procedures, some countries are unable to meet their national requirements for blood and blood components in a timely manner. Since establishment of Iran Blood Transfusion Organization (IBTO) in 1974 as an integral part of national healt...

Descripción completa

Detalles Bibliográficos
Autor principal: Cheraghali, AM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469026/
https://www.ncbi.nlm.nih.gov/pubmed/23113231
_version_ 1782246026541793280
author Cheraghali, AM
author_facet Cheraghali, AM
author_sort Cheraghali, AM
collection PubMed
description Despite importance of blood transfusion services as life saving procedures, some countries are unable to meet their national requirements for blood and blood components in a timely manner. Since establishment of Iran Blood Transfusion Organization (IBTO) in 1974 as an integral part of national health system, Iran has experienced a drastic improvement both in availability and safety of blood and blood products. Iran now has not only reached to a 100% non remunerated voluntary blood donation but also secured a national self sufficiency of blood and blood components. Efforts of IBTO as the sole player of transfusion medicines in Iran enabled the country for timely providing of life saving blood transfusion services for all Iranian patients in need of such services. In order to meet the country’s demand in 2011 about 2 million units of whole blood for a population of about 75 million collected by IBTO. This indicates 26.2 donations per 1000 population. Currently about 94% of blood donors in Iran are 25–35 years old males and contribution of female donors in blood donation is less than 6%. IBTO screen all donated blood for important transfusion transmissible infections such as HBV, HIV, HCV and syphilis. Prevalence of HBsAg, HCV and HIV in donated blood in IBTO in 2011 was 0.20%, 0.06% and 0.004% respectively.
format Online
Article
Text
id pubmed-3469026
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-34690262012-10-30 Overview of Blood Transfusion System of Iran: 2002–2011 Cheraghali, AM Iran J Public Health Report Article Despite importance of blood transfusion services as life saving procedures, some countries are unable to meet their national requirements for blood and blood components in a timely manner. Since establishment of Iran Blood Transfusion Organization (IBTO) in 1974 as an integral part of national health system, Iran has experienced a drastic improvement both in availability and safety of blood and blood products. Iran now has not only reached to a 100% non remunerated voluntary blood donation but also secured a national self sufficiency of blood and blood components. Efforts of IBTO as the sole player of transfusion medicines in Iran enabled the country for timely providing of life saving blood transfusion services for all Iranian patients in need of such services. In order to meet the country’s demand in 2011 about 2 million units of whole blood for a population of about 75 million collected by IBTO. This indicates 26.2 donations per 1000 population. Currently about 94% of blood donors in Iran are 25–35 years old males and contribution of female donors in blood donation is less than 6%. IBTO screen all donated blood for important transfusion transmissible infections such as HBV, HIV, HCV and syphilis. Prevalence of HBsAg, HCV and HIV in donated blood in IBTO in 2011 was 0.20%, 0.06% and 0.004% respectively. Tehran University of Medical Sciences 2012-08-31 /pmc/articles/PMC3469026/ /pubmed/23113231 Text en Copyright © Iranian Public Health Association & Tehran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Report Article
Cheraghali, AM
Overview of Blood Transfusion System of Iran: 2002–2011
title Overview of Blood Transfusion System of Iran: 2002–2011
title_full Overview of Blood Transfusion System of Iran: 2002–2011
title_fullStr Overview of Blood Transfusion System of Iran: 2002–2011
title_full_unstemmed Overview of Blood Transfusion System of Iran: 2002–2011
title_short Overview of Blood Transfusion System of Iran: 2002–2011
title_sort overview of blood transfusion system of iran: 2002–2011
topic Report Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469026/
https://www.ncbi.nlm.nih.gov/pubmed/23113231
work_keys_str_mv AT cheraghaliam overviewofbloodtransfusionsystemofiran20022011